152
Views
14
CrossRef citations to date
0
Altmetric
Research Article

Physicochemical investigation and in vivo activity of anti-malarial drugs co-loaded in Tween 80 niosomes

& ORCID Icon
Pages 315-321 | Received 14 Jun 2017, Accepted 02 Sep 2017, Published online: 26 Sep 2017

References

  • Abdul-Fattah, A.M. and Bhargava, H.N., 2002. Preparation and in vitro evaluation of solid dispersions of halofantrine. International journal of pharmaceutics, 235, 17–33.
  • Aditya, N.P., Patankar, S., and Madhusudhan, B., 2009. Assessment of curcumin-primaquine combination therapy for malaria. Pharmacology online, 3, 49–53.
  • Aggarwal, B.B., et al., 2007. Curcumin: the Indian solid gold. Advances in experimental medicine and biology, 595, 1–75.
  • Anand, P., et al., 2007. Bioavailability of curcumin: problems and promises. Molecular pharmaceutics, 4, 807–818.
  • Beutler, E., Duparc, S., and the G6PD Deficiency Working Group, 2007. Glucose-6-phosphate dehydrogenase deficiency and antimalarial drug development. The American journal of tropical medicine and hygiene, 77, 779–789.
  • Bhadra, D., et al., 2005. Glycodendrimeric nanoparticulate carriers of primaquine phosphate for liver targeting. International journal of pharmaceutics, 295, 221–233.
  • Cui, L., Miao, J., and Cui, L., 2007. Cytotoxic effect of curcumin on malaria parasite Plasmodium falciparum: inhibition of histone acetylation and generation of reactive oxygen species. Antimicrobial agents and chemotherapy, 51, 488–494.
  • Edwards, G. and Krishna, S., 2004. Pharmacokinetic and pharmacodynamic issues in the treatment of parasitic infections. European journal of clinical microbiology & infectious diseases, 2, 233–242.
  • Joshi, M., et al., 2008. Design and in vivo pharmacodynamics evaluation of nanostructured lipid carriers for parenteral delivery of artemether: nanoject. International journal of pharmaceutics, 364, 119–126.
  • Joshi, M., et al., 2008. Solid microemulsion preconcentrate (NanOsorb) of artemether for effective treatment of malaria. International journal of pharmaceutics, 362, 172–178.
  • Joshi, M., et al., 2013. An oral malaria therapy: curcumin-loaded lipid-based drug delivery systems combined with β-arteether. Journal of controlled release, 172, 904–913.
  • Kandasamy, R. and Veintramuthu, S., 2010. Formulation and optimization of zidovudine niosomes. AAPS PharmSciTech, 11, 1119–1127.
  • Kumar, G.P. and Rajeshwarrao, P., 2011. Nonionic surfactant vesicular systems for effective drug delivery – an overview. Acta pharmaceutica sinica B, 1, 208–219.
  • Osdene, T.S., Russell, P.B., and Rane, L., 1967. 2,4,7-Triamino-6-orthosubstituted arylpteridines. A new series of potent antimalarial agents. Journal of medicinal chemistry, 10, 431–436.
  • Owais, M., et al., 1995. Chloroquine-encapsulated in malaria-infected erythrocyte-specific antibody-bearing liposomes effectively controls chloroquine-resistant Plasmodium berghei infections in mice. Antimicrobial agents and chemotherapy, 39, 180–184.
  • Peters, W. and Robinson, B. L., 1999. Malaria. In: O. Zak and M. Sande, eds. Handbook of animal models of infection. London, UK: Academic Press, 757–773 (Chapter 92).
  • Pirson, P., Steiger, R., and Trouet, A., 1982. The disposition of free and liposomally encapsulated antimalarial primaquine in mice. Biochemical pharmacology, 31, 3501–3507.
  • Reddy, R.C., et al., 2005. Curcumin for malaria therapy. Biochemical and biophysical research communications, 326, 472–474.
  • Rodrigues, J.M., et al., 1995. Primaquine-loaded poly(lactide) nanoparticles: physicochemical study and acute tolerance in mice. International journal of pharmaceutics, 126, 253–260.
  • Rowland, M. and Durrani, N., 1999. Randomized controlled trials of 5- and 14-days primaquine therapy against relapses of vivax malaria in an Afghan settlement in Pakistan. Transactions of the royal society of tropical medicine and hygiene, 93, 641–643.
  • Stensrud, G., et al., 2000. Formulation and characterisation of primaquine loaded liposomes prepared by a pH gradient using experimental design. International journal of pharmaceutics, 198, 213–228.
  • Suresh, K., Bonepally, R., and Jithan, A., 2011. Enhanced liver delivery and sustained release of curcumin with drug loaded nanoparticles after intravenous administration in rats. Asian journal of pharmaceutical research & healthcare, 3, 99–108.
  • Visser, B.J., et al., 2014. Efficacy and safety of artemisinin combination therapy (ACT) for non-falciparum malaria: a systematic review. Malaria journal, 213, 463.
  • Visser, B.J., van Vugt, M., and Grobusch, M.P., 2014. Malaria: an update on current chemotherapy. Expert opinion on pharmacotherapy, 15 (15), 2219–2254.
  • White, N.J., 2004. Antimalarial drug resistance. The journal of clinical investigation, 113, 1084–1092.
  • White, N.J., 2008. Plasmodium knowlesi: the fifth human malaria parasite. Clinical infectious diseases, 46, 172–173.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.